Heron Therapeutics (HRTX) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Heron Therapeutics (HRTX) Net Income towards Common Stockholders Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Heron Therapeutics |
77.43 Mn |
47.47 Mn |
24.07 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
38.02% |
| Dec 31, 2025 |
14.88% |
| Sep 30, 2025 |
41.23% |
| Jun 30, 2025 |
50.62% |
| Mar 31, 2025 |
15.44% |
| Dec 31, 2024 |
15.67% |
| Sep 30, 2024 |
33.72% |
| Jun 30, 2024 |
34.08% |
| Mar 31, 2024 |
40.57% |
| Dec 31, 2023 |
27.58% |
| Sep 30, 2023 |
9.81% |
| Jun 30, 2023 |
-1.76% |
| Mar 31, 2023 |
8.66% |
| Dec 31, 2022 |
19.04% |
| Sep 30, 2022 |
-0.01% |
| Jun 30, 2022 |
-2.95% |
| Mar 31, 2022 |
-4.96% |
| Dec 31, 2021 |
-2.83% |
| Sep 30, 2021 |
-0.92% |
| Jun 30, 2021 |
-6.82% |
